Clinical trials
3 active studies led by HUINNO Co., Ltd, of 11 in all
Source: ClinicalTrials.gov, Studies with HUINNO Co., Ltd (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 2Markets in public records
- 0Regions & countries
- 3Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by HUINNO Co., Ltd or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on HUINNO Co., Ltd
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
1 510(k) clearances and PMA approvals since 2015
- Memo Patch M (Mpt-E08R-Unc01) K243438 · 5 Dec 2025
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Trials over time
Studies HUINNO Co., Ltd leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with HUINNO Co., Ltd or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show HUINNO Co., Ltd: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets HUINNO Co., Ltd is in.
From our blog
Stories on the topics HUINNO Co., Ltd works in.
Health Data Exchange: Why EDI Matters for Payers and Providers
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Wound Care: Advanced Dressings for Faster Healing
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read